Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 1/20 | 0.65 |
| ▸ | GNB1 | P62873 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.54 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 2/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | CDK2 | P24941 | 1/20 | 0.54 |
| ▸ | CHAT | P28329 | 1/20 | 0.54 |
| ▸ | BLVRB | P30043 | 1/20 | 0.54 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 6/20 | 0.49 |
| ▸ | SMAD3 | P84022 | 2/20 | 0.49 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29486978 | 0.93 | MEN1 (0.61) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL498286 | 0.93 | MEN1 (0.61) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL498536 | 0.90 | GNG2 (0.74) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL29740272 | 0.90 | GNG2 (0.74) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL30451804 | 0.85 | GNG2 (0.63) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL28626002 | 0.84 | FTO (0.70) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL8607854 | 0.81 | FTO (0.73) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL5886188 | 0.81 | MEN1 (0.58) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL3717351 | 0.80 | SMAD3 (0.45) | GNG2GNB1MEN1KMT2ATDP1 | |
| SCHEMBL30408346 | 0.80 | GNG2 (1.00) | GNG2GNB1MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842826-B2 | Process for synthesizing halogenated derivatives of fluorescein for use in the production of non-volatile memory devices | STMICROELECTRONICS S.R.L. (IT) | 2010-11-30 | — | — | US | claimed |
| US-20080061289-A1 | PROCESS FOR SYNTHESIZING HALOGENATED DERIVATIVES OF FLUORESCEIN FOR USE IN THE PRODUCTION OF NON-VOLATILE MEMORY DEVICES | STMICROELECTRONICS S.R.L. (IT) | 2008-03-13 | — | — | US | claimed |
| US-7842826-B2 | Process for synthesizing halogenated derivatives of fluorescein for use in the production of non-volatile memory devices | STMICROELECTRONICS S.R.L. (IT) | 2010-11-30 | — | — | US | disclosed |
| US-7842826-B2 | Process for synthesizing halogenated derivatives of fluorescein for use in the production of non-volatile memory devices | STMICROELECTRONICS S.R.L. (IT) | 2010-11-30 | — | — | US | disclosed |
| US-7842826-B2 | Process for synthesizing halogenated derivatives of fluorescein for use in the production of non-volatile memory devices | STMICROELECTRONICS S.R.L. (IT) | 2010-11-30 | — | — | US | disclosed |
| US-7842826-B2 | Process for synthesizing halogenated derivatives of fluorescein for use in the production of non-volatile memory devices | STMICROELECTRONICS S.R.L. (IT) | 2010-11-30 | — | — | US | disclosed |
| US-20080061289-A1 | PROCESS FOR SYNTHESIZING HALOGENATED DERIVATIVES OF FLUORESCEIN FOR USE IN THE PRODUCTION OF NON-VOLATILE MEMORY DEVICES | STMICROELECTRONICS S.R.L. (IT) | 2008-03-13 | — | — | US | disclosed |
| US-20080061289-A1 | PROCESS FOR SYNTHESIZING HALOGENATED DERIVATIVES OF FLUORESCEIN FOR USE IN THE PRODUCTION OF NON-VOLATILE MEMORY DEVICES | STMICROELECTRONICS S.R.L. (IT) | 2008-03-13 | — | — | US | disclosed |
| US-20080061289-A1 | PROCESS FOR SYNTHESIZING HALOGENATED DERIVATIVES OF FLUORESCEIN FOR USE IN THE PRODUCTION OF NON-VOLATILE MEMORY DEVICES | STMICROELECTRONICS S.R.L. (IT) | 2008-03-13 | — | — | US | disclosed |
| US-20080061289-A1 | PROCESS FOR SYNTHESIZING HALOGENATED DERIVATIVES OF FLUORESCEIN FOR USE IN THE PRODUCTION OF NON-VOLATILE MEMORY DEVICES | STMICROELECTRONICS S.R.L. (IT) | 2008-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080061289-A1 | PROCESS FOR SYNTHESIZING HALOGENATED DERIVATIVES OF FLUORESCEIN FOR USE IN THE PRODUCTION OF NON-VOLATILE MEMORY DEVICES | FASTKD5, KCNA5, KCNQ5 | GNG2 3802/4885GNB1 3231/4885MEN1 2830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.